tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CABA Stock Latest News

Cabaletta Bio price target raised to $30 from $15 at Cantor Fitzgerald
The FlyCabaletta Bio price target raised to $30 from $15 at Cantor Fitzgerald
3d ago
CABA
Cabaletta Bio Updates on CD19-CAR T Therapy Progress
PremiumCompany Announcements
Cabaletta Bio Updates on CD19-CAR T Therapy Progress
5d ago
8K
CABA
Cabaletta Bio’s Promising Clinical Advances and Strategic Plans Earn Buy Rating from Michael Ulz
PremiumRatings
Cabaletta Bio’s Promising Clinical Advances and Strategic Plans Earn Buy Rating from Michael Ulz
6d ago
CABA
Cabaletta Bio’s Innovative Myopathy Study: A Potential Game-Changer?
PremiumCompany Announcements
Cabaletta Bio’s Innovative Myopathy Study: A Potential Game-Changer?
6d ago
CABA
Cabaletta Bio’s Promising SLE Study: A Potential Game-Changer?
PremiumCompany Announcements
Cabaletta Bio’s Promising SLE Study: A Potential Game-Changer?
6d ago
CABA
Cabaletta Bio’s Promising Study on CABA-201 for Systemic Sclerosis: A Market Perspective
PremiumCompany AnnouncementsCabaletta Bio’s Promising Study on CABA-201 for Systemic Sclerosis: A Market Perspective
6d ago
CABA
Cabaletta Bio’s RESET-MG Study: A Potential Game-Changer for Myasthenia Gravis Treatment
Premium
Company Announcements
Cabaletta Bio’s RESET-MG Study: A Potential Game-Changer for Myasthenia Gravis Treatment
6d ago
CABA
Cabaletta Bio’s Promising Clinical Trial Results Lead to Buy Rating
Premium
Ratings
Cabaletta Bio’s Promising Clinical Trial Results Lead to Buy Rating
6d ago
CABA
Cabaletta Bio’s RESET-MS Study: A New Frontier in Multiple Sclerosis Treatment
PremiumCompany Announcements
Cabaletta Bio’s RESET-MS Study: A New Frontier in Multiple Sclerosis Treatment
6d ago
CABA
Cabaletta Bio’s Innovative Study on Pemphigus Vulgaris: A Potential Game-Changer
PremiumCompany Announcements
Cabaletta Bio’s Innovative Study on Pemphigus Vulgaris: A Potential Game-Changer
6d ago
CABA
Cabaletta Bio’s Innovative Dosing Strategy and Clinical Advancements Earn a Buy Rating
PremiumRatings
Cabaletta Bio’s Innovative Dosing Strategy and Clinical Advancements Earn a Buy Rating
6d ago
CABA
Cabaletta Bio Announces Positive Clinical Data Updates
PremiumCompany Announcements
Cabaletta Bio Announces Positive Clinical Data Updates
7d ago
8K
CABA
Cabaletta Bio presents data, development updates for Rese-cel
PremiumThe FlyCabaletta Bio presents data, development updates for Rese-cel
7d ago
CABA
Cabaletta Bio management to meet with Cantor Fitzgerald
Premium
The Fly
Cabaletta Bio management to meet with Cantor Fitzgerald
10d ago
CABA
Cabaletta Bio announces appointment of Gavel as CCO
Premium
The Fly
Cabaletta Bio announces appointment of Gavel as CCO
20d ago
CABA
3 Best Stocks to Buy Now, 10/10/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 10/10/2025, According to Top Analysts
24d ago
IVA
CABA
Promising Potential of Cabaletta Bio’s Rese-cel Therapy Drives Buy Rating
PremiumRatings
Promising Potential of Cabaletta Bio’s Rese-cel Therapy Drives Buy Rating
24d ago
CABA
Promising Early Data from Cabaletta Bio’s Rese-cel Therapy Suggests Significant Potential in Autoimmune Treatment
PremiumRatings
Promising Early Data from Cabaletta Bio’s Rese-cel Therapy Suggests Significant Potential in Autoimmune Treatment
24d ago
CABA
Cabaletta Bio jumps 30% to $3.13 after pemphigus vulgaris data
PremiumThe Fly
Cabaletta Bio jumps 30% to $3.13 after pemphigus vulgaris data
24d ago
CABA
Cabaletta Bio Presents Promising RESET-PV Trial Data
PremiumCompany AnnouncementsCabaletta Bio Presents Promising RESET-PV Trial Data
24d ago
8K
CABA
Cabaletta Bio presents initial dose data from RESET-PV trial of rese-cel
Premium
The Fly
Cabaletta Bio presents initial dose data from RESET-PV trial of rese-cel
24d ago
CABA
Cabaletta Bio: Buy Rating Backed by Promising Trial Data and Strategic Financial Outlook
Premium
Ratings
Cabaletta Bio: Buy Rating Backed by Promising Trial Data and Strategic Financial Outlook
1M ago
CABA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >